Fluid Retention Associated with Imatinib Treatment in Patients with Gastrointestinal Stromal Tumor: Quantitative Radiologic Assessment and Implications for Management-Reference-Cited by-同舟云学术

Fluid Retention Associated with Imatinib Treatment in Patients with Gastrointestinal Stromal Tumor: Quantitative Radiologic Assessment and Implications for Management

Published:2015 Issue:2 Volume:16 Page:304
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Kim Kyung Won¹²,Shinagare Atul B.¹,Krajewski Katherine M.¹,Pyo Junhee³,Tirumani Sree Harsha¹,Jagannathan Jyothi P.¹,Ramaiya Nikhil H.¹

Affiliation:

1. Department of Imaging, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

2. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Korea.

3. The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA.

Funder

Ministry of Health and Welfare

Publisher

The Korean Society of Radiology

Subject

Radiology Nuclear Medicine and imaging

Link

https://synapse.koreamed.org/pdf/10.3348/kjr.2015.16.2.304

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study;BMJ Open;2023-08

2. Imatinib-Induced Pleuro-Pericardial Effusion and Atrial Fibrillation: An Unusual Side Effect Following the Treatment of a Rare Gastrointestinal Tumor;Cureus;2023-04-17

3. CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity – a narrative review;Therapeutic Advances in Medical Oncology;2023-01

4. Chylous pericardial effusion with cardiac tamponade in a child treated with imatinib;Cardiology in the Young;2022-12-12

5. Cardiac Complications;Holland‐Frei Cancer Medicine;2022-10-21